Beta or gamma radiation.

China PharmaHub signs distribution agreement for radioactive cup sphere treatment for liver cancer China PharmaHub Corp. , which has recently merged with World Wide Relics which includes transformed its name to China PharmaHub Corp, and is along the way of obtaining acceptance from FINRA to trade under its new name with a new symbol, announced today that it has signed a special Distribution Agreement with a global leader in precision glass technology which may be useful to manufacture high accuracy radioactive glass spheres that emit alpha, beta or gamma radiation, either separately or in combination, for the treating malignant tumors of the liver. The Contract gives PharmaHub the exceptional to market in China, Hong Kong, Taiwan and Macau , Singapore, Malaysia, and Bangladesh this innovative liver cancer treatment which is comparable to a FDA-accepted liver cancers therapy cialis-forms/sildalis.html .